$170 Million
Exclusive Financial Advisor
Sale to The Medicines Company
April 2014
€42 Million
Exclusive Placement Agent
Private Placement
April 2014
$36 Million
Financial Advisor & Placement Agent
Merger & Series B Financing
April 2014
$60 Million
Sole Bookrunner
Initial Public Offering
April 2014
$62 Million
Joint Bookrunner
Follow-On
April 2014
$55 Million
Joint Bookrunner
Initial Public Offering
April 2014
$179 Million
Financial Advisor
Acquisition of Galapagos' Services Division
March 2014
$55 Million
Sole Bookrunner
Follow-On
March 2014
$61 Million
Sole Manager
Follow-On
March 2014
$27 Million
Exclusive Placement Agent
Series B Private Placement
March 2014
$84 Million
Sole Advisor
Acquisition of Ex-North America Rights from Bayer Consumer Care AG
March 2014
$50 Million
Sole Bookrunner
Follow-On
March 2014